Table 1.
General characteristics of patients with suspected COVID-19.
| Variable | Total (N=391) | Missing Data, No. (%) |
|---|---|---|
| Age, median (IQR), y | 62 (48–71) | 0 |
| Female sex | 150 (38.4) | 0 |
| ECOG PS | 104 (26.6) | |
| 0–2 | 257 (89.5) | |
| 3–4 | 30 (10.5) | |
| Immunosuppression | 195 (50.5) | 5 (1.3) |
| Diabetes mellitus | 68 (17.6) | |
| Solid cancer | 58 (15.0) | |
| Hematologic malignancy | 47 (12.2) | |
| Solid organ transplant | 14 (3.6) | |
| HIV | 23 (6.0) | |
| Extended corticosteroid course | 22 (5.7) | |
| Other | 16 (4.1) | |
| Chronic lung disease | 85 (22.1) | 6 (1.5) |
| COPD | 24 (6.2) | |
| Asthma | 22 (5.7) | |
| Lung cancer | 8 (2.0) | |
| Bronchiectasis/emphysema | 8 (2.0) | |
| Sarcoidosis/fibrosis | 7 (1.8) | |
| Other | 23 (6.0) | |
| Cardiovascular disease | 156 (40.4) | 5 (1.3) |
| Hypertension | 122 (31.6) | |
| Atrial fibrillation | 29 (7.4) | |
| Coronary disease | 22 (5.7) | |
| Chronic heart failure | 16 (4.1) | |
| Other | 5 (1.3) | |
| Obesity | 58 (15.2) | 9 (2.3) |
| No comorbidity | 70 (18.1) | 5 (1.3) |
IQR, Interquartile range; ECOG PS, Eastern Cooperative Oncology Group Performance Status; COPD chronic obstructive pulmonary disease.
Data are provided as No. (%) unless otherwise indicated.